A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)
Public ClinicalTrials.gov record NCT05662332. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Parallel-Design, Open-Label, Randomized Control Study to Evaluate the Efficacy and Safety of LY3209590 Administered Weekly Using a Fixed Dose Escalation Compared to Insulin Glargine in Insulin-Naïve Adults With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to determine the efficacy and safety of insulin efsitora alfa (LY3209590) administered weekly using a fixed dose escalation compared to insulin glargine in adults with type 2 diabetes (T2D) who are starting basal insulin therapy for the first time.
Study identification
- NCT ID
- NCT05662332
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 795 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 14, 2023 (Actual)
- Primary completion
- Jul 19, 2024 (Actual)
- Completion
- Jul 19, 2024 (Actual)
- Last update posted
- Aug 6, 2025
2023 – 2024
United States locations
- U.S. sites
- 39
- U.S. states
- 19
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Research | Birmingham | Alabama | 35242 | — |
| Syed Research Consultants Llc | Sheffield | Alabama | 35660 | — |
| AMCR Institute | Escondido | California | 92025 | — |
| Velocity Clinical Research, Gardena | Gardena | California | 90247 | — |
| National Research Institute - Huntington Park | Huntington Park | California | 90255 | — |
| National Research Institute - Wilshire | Los Angeles | California | 90057 | — |
| Diabetes Associates Medical Group | Orange | California | 92868 | — |
| Encompass Clinical Research | Spring Valley | California | 91978 | — |
| Millennium Clinical Trials | Thousand Oaks | California | 93065 | — |
| University Clinical Investigators, Inc. | Tustin | California | 92780 | — |
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | — |
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | — |
| Chase Medical Research, LLC | Waterbury | Connecticut | 06708 | — |
| Clinical Research of West Florida, Inc. (Clearwater) | Clearwater | Florida | 33765 | — |
| Suncoast Research Group | Miami | Florida | 33135 | — |
| Clinical Research of West Florida | Tampa | Florida | 33606 | — |
| Center for Advanced Research & Education | Gainesville | Georgia | 30501 | — |
| Pacific Diabetes & Endocrine Center | Honolulu | Hawaii | 96813 | — |
| Central Illinois Diabetes and Clinical Research a Division of Prairie Education and Research Cooperative | Springfield | Illinois | 62711 | — |
| American Health Network of Indiana, LLC - Franklin | Franklin | Indiana | 46131 | — |
| American Health Network of Indiana, LLC - Muncie | Muncie | Indiana | 47304 | — |
| Iowa Diabetes and Endocrinology Research Center | West Des Moines | Iowa | 50265 | — |
| Arcturus Healthcare , PLC, Troy Internal Medicine Research Division | Troy | Michigan | 48098 | — |
| Clinvest Research LLC | Springfield | Missouri | 65807 | — |
| University Of Nebraska Medical Center | Omaha | Nebraska | 68198-4130 | — |
| Mid Hudson Medical Research | New Windsor | New York | 12553 | — |
| Meridian Clinical Research, LLC | Vestal | New York | 13850 | — |
| Intend Research, LLC | Norman | Oklahoma | 73069 | — |
| Decpa, Llc | Feasterville-Trevose | Pennsylvania | 19053 | — |
| Office 18 | Pittsburgh | Pennsylvania | 15236 | — |
| WR-Clinsearch, LLC | Chattanooga | Tennessee | 37421 | — |
| Private Practice - Dr. Osvaldo A. Brusco | Corpus Christi | Texas | 78414 | — |
| Dallas Diabetes Research Center | Dallas | Texas | 75230 | — |
| Prime Revival Research Institute | Flower Mound | Texas | 75028 | — |
| Endocrine Associates | Houston | Texas | 77004 | — |
| Endocrine Ips, Pllc | Houston | Texas | 77079 | — |
| North Hills Family Medicine/North Hills Medical Research | North Richland Hills | Texas | 76180 | — |
| Texas Valley Clinical Research | Weslaco | Texas | 78596 | — |
| Eastside Research Associates | Redmond | Washington | 98052 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05662332, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 6, 2025 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05662332 live on ClinicalTrials.gov.